Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

834 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

NCT03399786

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Regeneron Research Site Boca Raton, Florida, United States
  • Regeneron Research Site Boston, Massachusetts, United States
  • Regeneron Research Site New York, United States
  • Regeneron Research Site Cincinnati, Ohio, United States
View all 30 locations
View Trial Details
Completed

Regeneron 1331 Kinetics Sub-Study HoFH

NCT04722068

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Department of Vascular Medicine Amsterdam UMC Amsterdam, AZ, Netherlands
View Trial Details
Completed

Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation

NCT00413595

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
Locations
  • Universitätsklinikum für Neurologie Graz, Austria
  • Department of Neurology, University Hospital Sestre Milosrdnice Zagreb, Croatia
  • Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires Lyon, France
  • Department of Neurology, S. Khechinashvili University clinic of Tbilisi state medical university Tbilisi, Georgia
View all 20 locations
View Trial Details
Completed

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

NCT00414583

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
Locations
  • Universitätsklinikum für Neurologie Graz, Austria
  • Department of Neurology, Universitaetsklinik fuer Neurologie Innsbruck Innsbruck, Austria
  • Wagner-Jauregg Linz, Department of Neurology Linz, Austria
  • Christian-Doppler-Klinik, Department für medizin. Studien Salzburg, Austria
View all 45 locations
View Trial Details
Completed

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease

NCT01268241

Conditions
Anderson-Fabry Disease, Brain Diseases, Brain Diseases, Metabolic, +21 more
Locations
  • Juan Fernandez Hospital, Department of Neurology Buenos Aires, Argentina
  • Unidad Renal Corrientes SRL, Medicina Interna Nefrólogo Corrientes, Argentina
  • UZA - University Ziekenhuis Antwerpen) Edegem, Belgium
  • University Hospital "Sestre Milosrdnice" Department of neuroimmunology and neurogenetic Zagreb, Croatia
View Trial Details
Completed

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

NCT02489344

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Investigational Site Number 840002 Atlanta, Georgia, United States
  • Investigational Site Number 840003 Cincinnati, Ohio, United States
  • Investigational Site Number 840001 Fairfax, Virginia, United States
  • Investigational Site Number 250001 Garches, France
View Trial Details

Related conditions